Ontology highlight
ABSTRACT: Background
The available evidence increasingly indicates that SERPINB3/4 plays a pivotal role in the progression of inflammatory diseases and may serve as a valuable biomarker for atopic dermatitis and psoriasis. However, the expression of SERPINB3/4 in the serum of patients with moderate-to-severe prurigo nodularis (PN) remains poorly understood.Objective
To find a promising biomarker for monitoring the severity and activity of moderate-to-severe PN patients.Methods
A total of 41 patients with moderate-to-severe PN and 20 healthy subjects were included in the study. Enzyme-linked immunosorbent assay (ELISA) was performed to determine serum SERPINB3/4 expression. Cutaneous SERPINB3/4 expression was evaluated by immunohistochemistry (IHC). Serum SERPINB3/4 levels wer
SUBMITTER: Wu J
PROVIDER: S-EPMC12461664 | biostudies-literature | 2025 Sep
REPOSITORIES: biostudies-literature